Intraoperative radiotherapy for locally advanced refractory cancer

Abe, M.; Takahashi, M.; Ono, K.; Dodo, Y.; Hiraoka, M.

Gan no Rinsho. Japan Journal of Cancer Clinics 29(6): 732-736

1983


ISSN/ISBN: 0021-4949
PMID: 6410105
Document Number: 213412
Clinical results of intraoperative radiotherapy (IOR) in carcinoma of the stomach and prostate, and malignant soft tissue tumors are reported. The 5-year survival rate was found to be increased by IOR in stages II-IV gastric cancer. From the analysis of the clinical results of prostatic cancer, a single dose of 3,500 rad was considered to be a potential curative dose for the tumor less than 3 cm in diameter. The local recurrence rate of patients with malignant soft tissue tumors who received a single dose ranging from 3,000 to 4,500 rad was 5.9 and the 5-year survival rate was 64.6%.

Document emailed within 1 workday
Secure & encrypted payments